Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RAS, Fibrinolysis and Cardiopulmonary Bypass

NCT00607672 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00607672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00607672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Lead sponsor
Vanderbilt University
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
December 31, 2011
Enrollment
111 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

angiotensin converting enzyme, angiotensin receptor blockers, cardiopulmonary bypass, coronary artery disease, fibrinolysis, inflammation